SEARCH

SEARCH BY CITATION

References

  • Au, W.Y., Fung, A., Man, C., Ma, S.K., Wan, T.S., Liang, R. & Kwong, Y.L. (2003) Aberrant p15 gene promoter methylation in therapy-related myelodysplastic syndrome and acute myeloid leukaemia: clinicopathological and karyotypic associations. British Journal of Haematology, 120, 10621065.
  • Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189199.
  • Brakensiek, K., Langer, F., Schlegelberger, B., Kreipe, H. & Lehmann, U. (2005) Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome. British Journal of Haematology, 130, 209217.
  • Chen, C.Y., Tsay, W., Tang, J.L., Shen, H.L., Lin, S.W., Huang, S.Y., Yao, M., Chen, Y.C., Shen, M.C., Wang, C.H. & Tien, H.F. (2003) SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia. Genes, Chromosomes and Cancer, 37, 300305.
  • Chen, C.Y., Lin, L.Y., Tang, J.H., Tsay, W., Chang, H.H., Yeh, Y.C., Huang, C.F., Chiou, R.C., Yao, M., Ko, B.S., Chen, Y.C., Lin, K.H., Lin, D.T. & Tien, H.F. (2006) Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome. Leukemia, 20, 11551158.
  • Chim, C.S., Fung, T.K., Cheung, W.C., Liang, R. & Kwong, Y.L. (2004a) SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway. Blood, 103, 46304635.
  • Chim, C.S., Wong, K.Y., Loong, F. & Srivastava, G. (2004b) SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak/STAT pathway. Leukemia, 18, 356358.
  • Chim, C.S., Wong, A.S. & Kwong, Y.L. (2004c) Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias. Annals of Hematology, 83, 527532.
  • Chou, W.C., Tang, J.L., Lin, L.I., Yao, M., Tsay, W., Chen, C.Y., Wu, S.J., Huang, C.F., Chiou, R.J., Tseng, M.H., Lin, D.T., Lin, K.H., Chen, Y.C. & Tien, H.F. (2006) Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution. Cancer Research, 66, 33103316.
  • Coffer, P.J., Koenderman, L. & De Groot, R.P. (2000) The role of STATs in myeloid differentiation and leukemia. Oncogene, 19, 25112522.
  • Fujitake, S., Hibi, K., Okochi, O., Kodera, Y., Ito, K., Akiyama, S. & Nakao, A. (2004) Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients. Journal of Gastroenterology, 39, 120124.
  • Galm, O., Yoshikawa, H., Esteller, M., Osieka, R. & Herman, J.G. (2003) SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood, 101, 27842788.
  • Galm, O., Wilop, S., Reichelt, J., Jost, E., Gehbauer, G., Herman, J.G. & Osieka, R. (2004) DNA methylation changes in multiple myeloma. Leukemia, 18, 16871692.
  • Galton, D.A. (1986) The myelodysplastic syndromes. Part I. What are they? Part II. Classification. Scandinavian Journal of Haematology. Supplementum, 45, 1120.
  • Geddes, A.A., Bowen, D.T. & Jacobs, A. (1990) Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndrome. British Journal of Haematology, 76, 194202.
  • Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. & Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 20792088.
  • Guo, M., House, M.G., Hooker, C., Han, Y., Heath, E., Gabrielson, E., Yang, S.C., Baylin, S.B., Herman, J.G. & Brock, M.V. (2004) Promoter hypermethylation of resected bronchial margins: a field defect of changes? Clinical Cancer Research, 10, 51315136.
  • Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D. & Baylin, S.B. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proceedings of the National Academy of Sciences of the United States of America, 93, 98219826.
  • Hilton, D.J., Richardson, R.T., Alexander, W.S., Viney, E.M., Willson, T.A., Sprigg, N.S., Starr, R., Nicholson, S.E., Metcalf, D. & Nicola, N.A. (1998) Twenty proteins containing a C-terminal SOCS box form five structural classes. Proceedings of the National Academy of Sciences of the United States of America, 95, 114119.
  • ISCN (1985) An International System for Human Cytogenetic Nomenclature. F.Mitelman (ed.). S Karger, Basel.
  • Issa, J.P., Garcia-Manero, G., Giles, F.J., Mannari, R., Thomas, D., Faderl, S., Bayar, E., Lyons, J., Rosenfeld, C.S., Cortes, J. & Kantarjian, H.M. (2004) Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies. Blood, 103, 16351640.
  • Iwai, M., Kiyoi, H., Ozeki, K., Kinoshita, T., Emi, N., Ohno, R. & Naoe, T. (2005) Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome. Leukemia, 19, 13671375.
  • Jacobs, R.H., Cornbleet, M.A., Vardiman, J.W., Larson, R.A., Le Beau, M.M. & Rowley, J.D. (1986) Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood, 67, 17651772.
  • Johan, M.F., Bowen, D.T., Frew, M.E., Goodeve, A.C. & Reilly, J.T. (2005) Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia. British Journal of Haematology, 129, 6065.
  • Knapp, R.H., Dewald, G.W. & Pierre, R.V. (1985) Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. Mayo Clinic Proceedings, 60, 507516.
  • Lin, S.Y., Yeh, K.T., Chen, W.T., Chen, H.C., Chen, S.T., Chiou, H.Y. & Chang, J.G. (2004) Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features. Oncology Reports, 11, 341348.
  • Liu, T.C., Lin, S.F., Chang, J.G., Yang, M.Y., Hung, S.Y. & Chang, C.S. (2003) Epigenetic alteration of the SOCS1 gene in chronic myeloid leukaemia. British Journal of Haematology, 123, 654661.
  • Lotem, J. & Sachs, L. (2002) Cytokine control of developmental programs in normal hematopoiesis and leukemia. Oncogene, 21, 32843294.
  • Lubbert, M. & Wijermans, P.W. (2005) Epigenetic therapy in MDS and acute AML: focus on decitabine. Annals of Hematology, 84(Suppl. 13), 12.
  • Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., Akira, S. & Kishimoto, T. (1997) Structure and function of a new STAT-induced STAT inhibitor. Nature, 387, 924929.
  • Okochi, O., Hibi, K., Sakai, M., Inoue, S., Takeda, S., Kaneko, T. & Nakao, A. (2003) Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis. Clinical Cancer Research, 9, 52955298.
  • Oshimo, Y., Kuraoka, K., Nakayama, H., Kitadai, Y., Yoshida, K., Chayama, K. & Yasui, W. (2004) Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma. International Journal of Cancer, 112, 10031009.
  • Ravandi, F., Talpaz, M., Kantarjian, H. & Estrov, Z. (2002) Cellular signalling pathways: new targets in leukaemia therapy. British Journal of Haematology, 116, 5777.
  • Rottapel, R., Ilangumaran, S., Neale, C., La Rose, J., Ho, J.M., Nguyen, M.H., Barber, D., Dubreuil, P. & De Sepulveda, P. (2002) The tumor suppressor activity of SOCS-1. Oncogene, 21, 43514362.
  • Starr, R., Metcalf, D., Elefanty, A.G., Brysha, M., Willson, T.A., Nicola, N.A., Hilton, D.J. & Alexander, W.S. (1998) Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proceedings of the National Academy of Sciences of the United States of America, 95, 1439514399.
  • Sutherland, K.D., Lindeman, G.J., Choong, D.Y., Wittlin, S., Brentzell, L., Phillips, W., Campbell, I.G. & Visvader, J.E. (2004) Differential hypermethylation of SOCS genes in ovarian and breast carcinomas. Oncogene, 23, 77267733.
  • Tien, H.F., Wang, C.H., Chuang, S.M., Chow, J.M., Lee, F.Y., Liu, M.C., Chen, Y.C., Shen, M.C., Lin, D.T. & Lin, K.H. (1994) Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome. A study on 68 Chinese patients in Taiwan. Cancer Genetics and Cytogenetics, 74, 4049.
  • Tien, H.F., Tang, J.H., Tsay, W., Liu, M.C., Lee, F.Y., Wang, C.H., Chen, Y.C. & Shen, M.C. (2001) Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation. British Journal of Haematology, 112, 148154.
  • To, K.F., Chan, M.W., Leung, W.K., Ng, E.K., Yu, J., Bai, A.H., Lo, A.W., Chu, S.H., Tong, J.H., Lo, K.W., Sung, J.J. & Chan, F.K. (2004) Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line. British Journal of Cancer, 91, 13351341.
  • Voso, M.T., Scardocci, A., Guidi, F., Zini, G., Di Mario, A., Pagano, L., Hohaus, S. & Leone, G. (2004) Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes. Blood, 103, 698700.
  • Watanabe, D., Ezoe, S., Fujimoto, M., Kimura, A., Saito, Y., Nagai, H., Tachibana, I., Matsumura, I., Tanaka, T., Kanegane, H., Miyawaki, T., Emi, M., Kanakura, Y., Kawase, I., Naka, T. & Kishimoto, T. (2004a) Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines. British Journal of Haematology, 126, 726735.
  • Watanabe, D., Naka, T. & Kishimoto, T. (2004b) Implication of SOCS-1 gene methylation in acute myeloid leukaemia. British Journal of Haematology, 127, 608609.
  • Yoshida, T., Ogata, H., Kamio, M., Joo, A., Shiraishi, H., Tokunaga, Y., Sata, M., Nagai, H. & Yoshimura, A. (2004) SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis. Journal of Experimental Medicine, 199, 17011707.
  • Yoshikawa, H., Matsubara, K., Qian, G.S., Jackson, P., Groopman, J.D., Manning, J.E., Harris, C.C. & Herman, J.G. (2001) SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nature Genetics, 28, 2935.